Publications by authors named "Pascal Mettens"

Claim this Profile
H
Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.
Clarisse Lorin, Yannick Vanloubbeeck, Sébastien Baudart, Michaël Ska, Babak Bayat, Pascal Mettens

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Marie-Cécile Mortier, Erik Jongert, Pascal Mettens, Jean-Louis Ruelle

BMC Immunol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
Eleonora G Thacher, Matthias Cavassini, Régine Audran, Anne-Christine Thierry, Anne Bollaerts, Pascal Mettens

AIDS· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.
Jaime Montoya, Juan Antonio Solon, Soledad Rosanna C Cunanan, Luz Acosta, Anne Bollaerts, Pascal Mettens

J Clin Immunol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
Cheryl L Day, Michele Tameris, Nazma Mansoor, Michele van Rooyen, Marwou de Kock, Pascal Mettens

Am J Respir Crit Care Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.
Isabel Leroux-Roels, Sheron Forgus, Fien De Boever, Frédéric Clement, Marie-Ange Demoitié, Pascal Mettens

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.
François Spertini, Régine Audran, Floriana Lurati, Opokua Ofori-Anyinam, Frédéric Zysset, Pascal Mettens

Tuberculosis (Edinb)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.
Clarisse Lorin, Lawrence Segal, Johann Mols, Danielle Morelle, Patricia Bourguignon, Pascal Mettens

Naunyn Schmiedebergs Arch Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
Rhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, Peter Probst, Brenda Barth, Pascal Mettens

FEMS Immunol Med Microbiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys.
Steven G Reed, Rhea N Coler, Wilfried Dalemans, Esterlina V Tan, Eduardo C DeLa Cruz, Pascal Mettens

Proc Natl Acad Sci U S A· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.
Pascal Mettens, Patrice M Dubois, Marie-Ange Demoitié, Babak Bayat, Marie-Noëlle Donner

Vaccine· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.
Jennifer L Oliver, Ghazaleh Pashmi, Paul Barnett, Pascal Mettens, Ralph Biemans

Vaccine· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
V Ann Stewart, Shannon M McGrath, Patrice M Dubois, Maria G Pau, Pascal Mettens

Infect Immun· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
Clara Brando, Lisa A Ware, Helen Freyberger, April Kathcart, Arnoldo Barbosa, Pascal Mettens

Infect Immun· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life-style vaccines.
Pascal Mettens, Philippe Monteyne

Br Med Bull· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis